跳至主要内容
临床试验/CTRI/2020/11/028959
CTRI/2020/11/028959尚未招募未知

Comparison of outcome in Coronavirus disease 2019 (COVID-19) pneumonia patients with or without recombinant erythropoietin (r-EPO) â?? a prospective randomized controlled study.

All India Institute Of Medical Sciences New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • sars-cov-2 positive patients.
  • moderate to severe disease who require non-invasive or invasive ventilation.

排除标准

  • patients relative refusal.
  • terminal end-organ failure (renal, liver, cardiac, cns)
  • thrombocytosis.
  • concomitant potential serious infections.

研究者

发起方
All India Institute Of Medical Sciences New Delhi

相似试验

Effect of recombinant erythropoietin in covid-19... | 临床试验